Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer

BACKGROUND: Epithelial-mesenchymal transition (EMT), one leading reason of the dismal prognosis of bladder cancer (BLCA), is closely associated with tumor invasion and metastasis. We aimed to develop a novel immune−related gene signature based on different EMT and metabolic status to predict the pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhao, Yu, Yongbo, Li, Peng, Wang, Meilan, Jiao, Wei, Liang, Ye, Niu, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359097/
https://www.ncbi.nlm.nih.gov/pubmed/35958586
http://dx.doi.org/10.3389/fimmu.2022.954616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359097/
https://www.ncbi.nlm.nih.gov/pubmed/35958586
http://dx.doi.org/10.3389/fimmu.2022.954616

Ejemplares similares